These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25910931)

  • 1. Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.
    Lin MT; Chang CH; Sun LC; Liu HM; Chang HW; Chen CA; Chiu SN; Lu CW; Chang LY; Wang JK; Wu MH
    J Formos Med Assoc; 2016 May; 115(5):350-5. PubMed ID: 25910931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.
    Kobayashi T; Inoue Y; Takeuchi K; Okada Y; Tamura K; Tomomasa T; Kobayashi T; Morikawa A
    Circulation; 2006 Jun; 113(22):2606-12. PubMed ID: 16735679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hibiscus score: Developing and validating a predictive tool for intravenous immunoglobulin treatment resistance in Malaysian children with Kawasaki disease.
    Tan JYC; Ng SY; Chan HK; Wong PM; Mohamed Zabidi H; Abu Hassan MR
    J Cardiol; 2024 Dec; 84(6):362-365. PubMed ID: 38852775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD
    Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S; Kawashima H; Kashiwagi Y; Hoshika A
    Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease.
    Piram M; Darce Bello M; Tellier S; Di Filippo S; Boralevi F; Madhi F; Meinzer U; Cimaz R; Piedvache C; Koné-Paut I
    Sci Rep; 2020 Feb; 10(1):3125. PubMed ID: 32080307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indicators of unresponsiveness after initial i.v. immunoglobulin treatment in acute Kawasaki disease.
    Hashimoto I
    Pediatr Int; 2019 Jul; 61(7):641-646. PubMed ID: 31132210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of risk scores for predicting intravenous immunoglobulin resistance in Taiwanese patients with Kawasaki disease.
    Huang CN; Wu FF; Chang YM; Huang HC; Lin MT; Wang JK; Wu MH
    J Formos Med Assoc; 2021 Oct; 120(10):1884-1889. PubMed ID: 33358267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population.
    Tang Y; Yan W; Sun L; Huang J; Qian W; Ding Y; Lv H
    Clin Rheumatol; 2016 Nov; 35(11):2771-2776. PubMed ID: 27491972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease.
    Qian W; Tang Y; Yan W; Sun L; Lv H
    Ital J Pediatr; 2018 Mar; 44(1):33. PubMed ID: 29523168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
    Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1B polymorphism in association with initial intravenous immunoglobulin treatment failure in Taiwanese children with Kawasaki disease.
    Weng KP; Hsieh KS; Ho TY; Huang SH; Lai CR; Chiu YT; Huang SC; Lin CC; Hwang YT; Ger LP
    Circ J; 2010 Mar; 74(3):544-51. PubMed ID: 20081319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of intravenous immunoglobulin non-responders in Kawasaki disease.
    Hwang JY; Lee KY; Rhim JW; Youn YS; Oh JH; Han JW; Lee JS; Burgner D
    Arch Dis Child; 2011 Nov; 96(11):1088-90. PubMed ID: 20551193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do cytokines correlate with refractory Kawasaki disease in children?
    Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
    Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shock and unresponsiveness to repeated courses of intravenous immunoglobulin in Kawasaki disease: a nationwide database study.
    Liang YC; Chang CH; Lin MT; Kao FY; Huang SK; Wu MH
    Pediatr Res; 2020 Apr; 87(5):961-966. PubMed ID: 31711068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance.
    Tajima M; Shiozawa Y; Kagawa J
    Pediatr Cardiol; 2015 Aug; 36(6):1159-65. PubMed ID: 25753685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
    Iwashima S; Kimura M; Ishikawa T; Ohzeki T
    Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.
    Sánchez-Manubens J; Antón J; Bou R; Iglesias E; Calzada-Hernandez J; Borlan S; Gimenez-Roca C; Rivera J;
    Rheumatol Int; 2016 Jul; 36(7):905-10. PubMed ID: 27215220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.